An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

Clinical trial NCT05765773 · COMPLETED

Trial details

NCT number: NCT05765773
Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection Vaccine COVID-19

Start date: 2021-07-01
Primary completion: 2022-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.